These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26479464)

  • 1. Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis.
    Upshaw JN; Kiernan MS; Morine KJ; Kapur NK; DeNofrio D
    ASAIO J; 2016; 62(1):33-9. PubMed ID: 26479464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
    Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D
    Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.
    Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS
    ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal anticoagulation in patients with a left ventricular assist device?
    Rossi M; Serraino GF; Jiritano F; Renzulli A
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.
    Badiye A; Hernandez GA; Chaparro S
    ASAIO J; 2014; 60(3):361-5. PubMed ID: 24614354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.